Efficacy and Safety of Direct Oral Anticoagulants in Budd–Chiari Syndrome After Percutaneous Recanalization
DOACs may be an effective and safe alternative to VKAs for patients with BCS after percutaneous recanalization. Further prospective studies are needed to confirm these findings.
Authors
- Guofeng Liu (ORCID: https://orcid.org/0000-0002-2835-9547)
- Xiaoze Wang (ORCID: https://orcid.org/0000-0002-7169-9467)
- Xuefeng Luo (ORCID: https://orcid.org/0000-0002-3992-5866)
- Yi Shen (ORCID: https://orcid.org/0000-0002-6548-7089)
- Chengjian Wu
- Zhaoyan Gao (ORCID: https://orcid.org/0009-0001-7603-3867)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Hepatology Research
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1111/hepr.70057
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00